Literature DB >> 23524334

Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.

Jean-Charles Neel1, Jean-Jacques Lebrun.   

Abstract

MicroRNA-181 (miR-181) is a multifaceted miRNA that has been implicated in many cellular processes such as cell fate determination and cellular invasion. While miR-181 is often overexpressed in human tumors, a direct role for this miRNA in breast cancer progression has not yet been characterized. In this study, we found this miRNA to be regulated by both activin and TGFβ. While we found no effect of miR-181 modulation on activin/TGFβ-mediated tumor suppression, our data clearly indicate that miR-181 plays a critical and prominent role downstream of two growth factors, in mediating their pro-migratory and pro-invasive effects in breast cancer cells miR-181 acts as a metastamir in breast cancer. Thus, our findings define a novel role for miR-181 downstream of activin/TGFβ in regulating their tumor promoting functions. Having defined miR-181 as a critical regulator of tumor progression in vitro, our results thus, highlight miR-181 as an important potential therapeutic target in breast cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524334     DOI: 10.1016/j.cellsig.2013.03.013

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

1.  miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.

Authors:  Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

2.  Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.

Authors:  Hongmei Xu; Jihong Zhu; Cong Hu; Hua Song; Yiyang Li
Journal:  J Physiol Biochem       Date:  2016-08-18       Impact factor: 4.158

3.  MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.

Authors:  Zhu Jianwei; Liu Fan; Liu Xiancheng; Bai Enzhong; Li Shuai; Li Can
Journal:  Tumour Biol       Date:  2013-06-06

4.  LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Authors:  Yanbei Sun; Tingxiu Jiang; Yongqing Jia; Jingyun Zou; Xiaoxiao Wang; Weiying Gu
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

5.  MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Authors:  Chun-Hua Xu; Li-Min Xiao; Er-Ming Zeng; Li-Ke Chen; Su-Yue Zheng; Dong-Hai Li; Yue Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 6.  The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.

Authors:  Darcie D Seachrist; Ruth A Keri
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 7.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

8.  miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.

Authors:  Xiaoling She; Zhibin Yu; Yulong Cui; Qianqian Lei; Zeyou Wang; Gang Xu; Zhaohui Luo; Guiyuan Li; Minghua Wu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

9.  Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs.

Authors:  Steven R Presnell; Ahmad Al-Attar; Frank Cichocki; Jeffrey S Miller; Charles T Lutz
Journal:  Genes Immun       Date:  2014-11-20       Impact factor: 2.676

10.  TGF-β Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth.

Authors:  Sabrina Carrella; Sara Barbato; Ylenia D'Agostino; Francesco Giuseppe Salierno; Anna Manfredi; Sandro Banfi; Ivan Conte
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.